Absci (ABSI) Competitor Comparison
We are evaluating the key criteria listed to compare Absci (ABSI) against its competitors in the Biotechnology industry.
Market Capitalization
178 / 368Gross Profits
0 / 278Total Revenue
193 / 300EBITDA
172 / 337Free Cashflow
183 / 352Quick Ratio
214 / 357Earnings per Share
124 / 359Dividend yield
0 / 6Total Cash
206 / 358Performance 3 years
224 / 368Performance 5 years
239 / 368Performance 10 years
213 / 368Linearity 3 years
180 / 368Linearity 5 years
274 / 368Linearity 10 years
257 / 368Total Rank
50 / 368Dividend Rank
323 / 368Valuation Rank
67 / 368Piotroski Rank
225 / 368Muliplier Rank
248 / 368Total Revenue - ABSI ranking 193 / 300
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.